Middle East Pharmaceutical Industries Company (TADAWUL:4016)

Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
61.60
+0.60 (0.98%)
Jun 11, 2026, 3:16 PM AST
Market Cap2.16B -14.6%
Revenue (ttm)493.25M +18.7%
Net Income104.51M +16.3%
EPS2.99 +16.3%
Shares Out 35.00M
PE Ratio20.63
Forward PEn/a
Dividend1.38 (2.24%)
Ex-Dividend DateMar 30, 2026
Volume193,157
Open61.00
Previous Close61.00
Day's Range60.70 - 62.05
52-Week Range53.89 - 79.09
Beta0.48
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About TADAWUL:4016

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally. The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infectives, musculoskeletal, genitourinary systems, and CNS. It exports its products. The company was formerly known as Middle East Chemical Products Factory Compan... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 1998
Employees 731
Stock Exchange Saudi Stock Exchange
Ticker Symbol 4016
Full Company Profile

Financial Performance

In 2025, TADAWUL:4016's revenue was 460.48 million, an increase of 16.87% compared to the previous year's 394.00 million. Earnings were 97.01 million, an increase of 21.49%.

Financial Statements